These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 33835386)
1. Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance. Ferrara F; Vitiello A Cardiovasc Toxicol; 2021 Jun; 21(6):498-503. PubMed ID: 33835386 [TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections. Ferrara F; Vitiello A Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1589-1593. PubMed ID: 34151392 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. Shukla AK; Banerjee M High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533 [TBL] [Abstract][Full Text] [Related]
4. ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019). Foroozanfar E; Forouzanfar M; Farkhondeh T; Samarghandian S; Forouzanfar F Curr Drug Discov Technol; 2021; 18(6):e130921189567. PubMed ID: 33371835 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019. Suh SH; Ma SK; Kim SW; Bae EH Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712 [TBL] [Abstract][Full Text] [Related]
6. An update on ACE2 amplification and its therapeutic potential. Marquez A; Wysocki J; Pandit J; Batlle D Acta Physiol (Oxf); 2021 Jan; 231(1):e13513. PubMed ID: 32469114 [TBL] [Abstract][Full Text] [Related]
7. ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases. Bank S; De SK; Bankura B; Maiti S; Das M; A Khan G Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33442728 [TBL] [Abstract][Full Text] [Related]
8. The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection. Penninger JM; Grant MB; Sung JJY Gastroenterology; 2021 Jan; 160(1):39-46. PubMed ID: 33130103 [TBL] [Abstract][Full Text] [Related]
9. ACE2: from protection of liver disease to propagation of COVID-19. Warner FJ; Rajapaksha H; Shackel N; Herath CB Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956 [TBL] [Abstract][Full Text] [Related]
10. COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial. Mancia G Cardiovasc Res; 2020 Dec; 116(14):e198-e199. PubMed ID: 33245754 [No Abstract] [Full Text] [Related]
11. Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2. Hallaj S; Ghorbani A; Mousavi-Aghdas SA; Mirza-Aghazadeh-Attari M; Sevbitov A; Hashemi V; Hallaj T; Jadidi-Niaragh F Immunol Cell Biol; 2021 Feb; 99(2):192-205. PubMed ID: 32864784 [TBL] [Abstract][Full Text] [Related]
12. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV. Lubbe L; Cozier GE; Oosthuizen D; Acharya KR; Sturrock ED Clin Sci (Lond); 2020 Nov; 134(21):2851-2871. PubMed ID: 33146371 [TBL] [Abstract][Full Text] [Related]
13. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110 [TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system at the interface of COVID-19 infection. Gul R; Kim UH; Alfadda AA Eur J Pharmacol; 2021 Jan; 890():173656. PubMed ID: 33086029 [TBL] [Abstract][Full Text] [Related]
15. Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patients. Latil M; Camelo S; Veillet S; Lafont R; Dilda PJ Drug Discov Today; 2021 May; 26(5):1311-1318. PubMed ID: 33609783 [TBL] [Abstract][Full Text] [Related]
16. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662 [TBL] [Abstract][Full Text] [Related]
17. The concern about ACE/ARB and COVID-19: Time to hold your horses! Pergolizzi JV; Varrassi G; Magnusson P; LeQuang JA; Leopoulou M; Paladini A; Taylor R; Wollmuth C; Breve F; J Am Pharm Assoc (2003); 2020; 60(6):e88-e90. PubMed ID: 32747165 [TBL] [Abstract][Full Text] [Related]
18. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866 [TBL] [Abstract][Full Text] [Related]
19. Manipulation of ACE2 expression in COVID-19. Chaudhry F; Lavandero S; Xie X; Sabharwal B; Zheng YY; Correa A; Narula J; Levy P Open Heart; 2020 Dec; 7(2):. PubMed ID: 33443121 [TBL] [Abstract][Full Text] [Related]
20. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes. Guney C; Akar F J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]